Search Results - "Pallardo Mateu, L"

Pretransplant Donor-Specific HLA Antibodies Detected by Single Antigen Bead Flow Cytometry: Risk Factors and Outcomes After Kidney Transplantation by Kanter Berga, J, Sancho Calabuig, A, Gavela Martinez, E, Puig Alcaraz, N, Beltran Catalan, S, Avila Bernabeu, A, Crespo Albiach, J, Montoro, J.A, Pallardo Mateu, L.M

“…Abstract Background The clinical significance of pretransplant donor-specific antibodies (pre-Tx DSAs) detected by single antigen bead flow cytometry (SAB-FC)…”
Get full text

Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation by Berga, J. Kanter, Mateu, L.M. Pallardo, Catalan, S. Beltran, Alcaraz, N. Puig, Calabuig, A. Sancho, Martinez, E. Gavela, Bernabeu, A. Avila, Albiach, J. Crespo

“…Abstract Background Anti–human leukocyte antigen antibodies (HLA Abs) have been associated with reduced kidney allograft survival. Our aim was to analyze the…”
Get full text

Vitamin D Deficiency in a Renal Transplant Population: Safe Repletion With Moderate Doses of Calcidiol by Kanter Berga, J, Crespo Albiach, J, Beltran Catalan, S, Gavela Martinez, E, Sancho Calabuig, A, Avila Bernabeu, A, Pallardo Mateu, L.M

“…Abstract Background Deficits of vitamin D are a common finding in the general population, especially among patients with chronic kidney disease. However, there…”
Get full text

Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody–Low Titers by Kanter Berga, J, Sancho Calabuig, A, Gavela Martinez, E, Puig Alcaraz, N, Avila Bernabeu, A, Crespo Albiach, J, Molina Vila, P, Beltrán Catalan, S, Pallardó Mateu, L

“…Abstract Background Kidney transplantation is the better option for end-stage renal disease (ESRD), but for patients with human leukocyte antigen (HLA)…”
Get full text

Delayed Graft Function After Renal Transplantation: An Unresolved Problem by Gavela Martínez, E, Pallardó Mateu, L.M, Sancho Calabuig, A, Beltrán Catalán, S, Kanter Berga, J, Ávila Bernabeu, A.I, Crespo Albiach, J

“…Abstract Unlike other areas in renal transplantation, delayed graft function (DGF) remains an apparently unavoidable complication owing to the characteristics…”
Get full text

Safety and Efficacy of Induction Treatment with Low Thymoglobulin Doses in Kidney Transplantation from Expanded-Criteria Donors by Sancho Calabuig, A, Gavela Martínez, E, Kanter Berga, J, Beltrán Calatán, S, Avila Bernabeu, A.I, Pallardó Mateu, L.M

“…Abstract Background Induction treatment has been recommended as part of the initial immunosuppressive regimen in kidney transplantation, and antithymocyte…”
Get full text

Genetic Polymorphisms and Individualized Tacrolimus Dosing by López-Montenegro Soria, M.A, Kanter Berga, J, Beltrán Catalán, S, Milara Payá, J, Pallardó Mateu, L.M, Jiménez Torres, N.V

“…Abstract Background Genetic polymorphisms of metabolism enzymes or intestinal drug transporters may affect pharmacokinetic responses to immunosuppressive drugs…”
Get full text

Very Low-Grade Proteinuria at 3 Months Posttransplantation Is an Earlier Marker of Graft Survival by Sancho Calabuig, A, Pallardó Mateu, L.M, Avila Bernabeu, A.I, Gavela Martínez, E, Beltrán Catalán, S, Crespo Albiach, J.F

“…Abstract Proteinuria is an early finding that appears in the first 3 months after transplantation in half of patients. Frequently, it is very low grade (VLP;…”
Get full text

Induction Treatment With Low-Dose Thymoglobulin or Basiliximab in Renal Transplants From Older Donors by Gavela Martínez, E, Sancho Calabuig, A, Escudero Quesada, V, Ávila Bernabeu, A.I, Beltrán Catalán, S, Morales García, A.I, Crespo Albiach, J.F, Pallardó Mateu, L.M

“…Abstract Transplantation of kidneys from older donors is followed by an increase in delayed graft function (DGF) and acute rejection episodes (ARE). In these…”
Get full text

Use of Basiliximab Induction in Low–Immunological Risk Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression by Gavela Martı́nez, E, Ávila Bernabeu, A.I, Sancho Calabuig, A, Beltrán Catalán, S, Escudero Quesada, V, Pallardó Mateu, L.M

“…Abstract Basiliximab induction treatment has been shown to reduce the incidence of acute rejection episodes without the secondary side effects observed with…”
Get full text

Vasculitis with acute kidney failure and torasemide by Palop-Larrea, Vicente, Sancho-Calabuig, Asunción, Gorriz-Teruel, José L, Martinez-Mir, Inocencia, Pallardó-Mateu, Luis M

“…Palop-Larrea et al discuss two patients who had vasculitis with kidney failure related to torasemide administration--an adverse drug reaction not previously…”
Get full text

Analysis of variability in determining intact parathyroid hormone (iPTH) according to the method used to process the sample by Morales García, A I, Górriz Teruel, J L, Plancha Mansanet, M C, Escudero Quesada, V, Pallardó Mateu, L M

“…The measurement of i-PTH circulating is not easy due to its analytical variablity. Variability that appears in the process that goes from the sample collection…”
Get full text

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation by ROSTAING, Lionel, CANTAROVICH, Diego, ORTUNO-MIRETE, Joaquin, CHARPENTIER, Bernard, LEGENDRE, Christophe, SANCHEZ-PLUMED, Jaime, OPPENHEIMER, Federico, KESSLER, Michele, MOURAD, Georges, BUDDE, Klemens, RIGOTTI, Paolo, MARIAT, Christophe, MARGREITER, Raimund, CAPDEVILLA, Luis, LANG, Phillippe, VIALTEL, Paul

“…Corticosteroid-free maintenance immunosuppression after organ transplantation eliminates the well-known corticosteroid-related side effects and may help to…”
Get full text

Pretransplant Donor-Specific HLA Antibodies: Risk Factors and Outcomes after Kidney Transplantation: 1227 by Kanter Berga, J., Gavela Martinez, E., Puig Alcaraz, N., Sancho Calabuig, A., Pallardo Mateu, L.

Get full text

Urinary NGAL after Kidney Transplantation: Is it a Good Biomarker to Assess Delayed Graft Function?: 1273 by Kanter Berga, J., Beltran Catalan, S., Gavela Martinez, E., Sancho Calabuig, A., Pallardo Mateu, L.

Get full text

Hepatitis E Virus Infection in Renal Transplantation: Report of Four Cases: 1493 by Kanter Berga, J., Rodriguez Mendez, G., Crespo Albiach, J., Sancho Calabuig, A., Gavela Martinez, E., Anton Conejero, M. D., Pallardo Mateu, L.

Get full text

Acute rejection and late renal transplant failure: Risk factors and prognosis by Pallardó Mateu, Luis M., Sancho Calabuig, Asunción, Capdevila Plaza, Lluis, Franco Esteve, Antonio

“…Background. Acute rejection episodes are a major determinant of renal allograft survival, and the improvement of the transplantation results in the last two…”
Get full text

Delayed spontaneous rupture of the kidney graft by Kanter Berga, J, Cáceres Borrero, C, Ripollés González, T, Avila Bernabeu, A, Gavela Martínez, E, Pallardó Mateu, L

Get full text

CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy by Gómez-Álvarez, S, Llopis-Salvia, P, Avila-Bernabeu, A, Pallardó-Mateu, L, Climente-Martí, M

“…BackgroundAtypical haemolytic uraemic syndrome (aHUS) is a rare, life-threatening, chronic thrombotic microangiopathy (TMA) caused by uncontrolled complement…”
Get full text

Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA Study) by López Revuelta, Katia, García López, Fernando J., de Álvaro Moreno, Fernando, Alonso, Jordi

“…Background. Health-related quality of life may affect morbidity and survival in end-stage renal disease, but it is not clear whether coexisting comorbidity and…”
Get full text